Kelly named director of cardiovascular division
Daniel Kelly, M.D., has been named director of the Division of Cardiovascular Diseases in the Department of Medicine.
Shapiro to give Dean’s Update
Dean Shapiro plans to give updates on the School of Medicine’s key initiatives, including the tobacco-free initiative, addressing pandemic flu, and the New Interstate 64 project.
Amendment 2 passage urged by Missouri’s top medical educators
Deans and top administrators from Missouri’s seven medical higher education institutions have joined to urge the passage of the Missouri Stem Cell Research and Cures Initiative.
Van Gelder named Becker Professor of Ophthalmology and Visual Sciences
A specialist with the Barnes Retina Institute, Van Gelder also directs the Uveitis Service for the Department of Ophthalmology and Visual Sciences.
Pump it up
Photo by Robert BostonThe staff at the Washington University Diabetes Center at Barnes-Jewish Hospital discuss nutrition and insulin pumps at the Open House Sept. 25.
High-energy clamp simplifies heart surgery
Using radiofrequency devices, School of Medicine heart surgeons have shortened atrial fibrillation surgery and made it easier to perform.
School of Medicine to hold ‘smokeout’ event
At the School of Medicine “smokeout” Nov. 16, employees who smoke will receive a special gift in exchange for their cigarettes.
Safety measure adopted by Siteman Cancer Center
A new device used at Siteman Cancer Center will protect staff from the possibility of incidental exposure to trace amounts of chemotherapy drugs generated during administration.
Siteman Cancer Center gains nationally recognized leader in cancer prevention
ColditzGraham A. Colditz, M.D., Dr.P.H., has been named the Niess-Gain Professor and associate director of Prevention and Control at the Siteman Cancer Center at the School of Medicine and Barnes-Jewish Hospital. He will have overall responsibility for overseeing research, education, and community outreach in cancer prevention sponsored by the Center.
Naturally occurring enzyme can break down key part of Alzheimer’s plaques
Scientists have identified a naturally occurring enzyme that can break down a key component of the brain plaques characteristic of Alzheimer’s disease. The finding may provide researchers with new opportunities to understand what goes wrong in the brains of Alzheimer’s patients and could one day help them seek new therapies.
View More Stories